February 12, 2025 – The Israeli Phage Therapy Center (IPTC) is naming a newly discovered phage (KpRaz1) discovered by researcher Sigal Vorzhev in honor of her late life partner, Maj. Gen. Raz Abulafia, who fell in battle during the war following the Oct. 7 attacks.

The IPTC, a joint venture of the Hadassah Medical Center and the Hebrew University of Jerusalem, provides treatment that uses viruses called bacteriophages (phages) to target and kill harmful bacteria.

As part of her biotechnology studies, Sigal, together with her research associate Shira Meuchas-Heilbron, is melding her personal loss with cutting-edge scientific work in naming KpRaz1 phage.

Vorzhev said, “Naming this phage after Raz is my way of honoring his memory—not only as a soldier and a leader but as someone who dedicated his life to protecting others. If KpRaz1 can one day help save lives, it will be a tribute worthy of him. If it proves effective in treating bacterial infections, it could potentially save lives.”

The center, which focuses on using phages to combat antibiotic-resistant bacteria, has been naming newly discovered phages after fallen heroes from the conflict. Each newly isolated phage at IPTC is assigned a name, often honoring individuals whom the researchers admire, such as historical figures, respected scientists in the phage research field, or even family members of the team.

Following the outbreak of the War of the Iron Swords, the lab decided to name newly discovered phages after fallen soldiers and other Israeli civilians as a tribute to their memory. Among those commemorated are Alon Shimriz, Yanai Kaminka, and Arnon Zmora.

According to Prof. Avraham Zini, Dean of the Hebrew University Faculty of Dental Medicine, “This initiative embodies the intersection of scientific innovation and deep personal tribute. Through Sigal’s and Shira’s work, we not only advance the fight against antibiotic-resistant bacteria but also ensure that the legacy of fallen heroes continues in a meaningful and lifesaving way.”